CivicScience has data on over 170K current GLP-1 users, providing a unique lens into these medications societal, cultural, and economic impact
A new Ozempic rival helps patients lose fat, but keep their muscle the holy grail for a weight-loss drug It's the holy grail for a weight-loss drug: Stay strong, but lose the fat
This isn't a stall it's expected
Cultural attitudes toward obesity as a condition requiring pharmacological intervention also remain more conservative than in Western markets
Low IGF-1 levels indicate GH deficiency or receptor insensitivity
The unique combination of protein, L-Carnitine, and vitamins supports active lifestyles, making it ideal for athletes, fitness enthusiasts, and health-conscious professionals looking for a clean energy solution